2019-11-13T12:34:53-06:00 2018-12-31 ERNST & YOUNG US LLP 2100 ONE PPG PLACE PITTSBURGH PA 15222 990 2018-01-01 900593925 THE SUBSIDIARIES OF THE INSTITUTE FOR TRANSFUSION MEDICINE % CHARLES LACLAIR SUBS 4122097300 875 GREENTREE RD PC5 PITTSBURGH PA 15220 TANYA PERRY CFO 4806755503 2019-11-11 James L Ziesche P01264584 4126447800 164.57.159.254 25553720193165000024 2019-11-12 P A4485482F404CA549E8704298C27367BFA2421D5 E3B1A43203BA05827699019DAE8F50E356F9BE12 2018 2020-03-31 21:24:44Z TANYA PERRY 6210 E OAK STREET SCOTTSDALE AZ 85257 227534138 true true 5645 X www.itxm.org X PA TO PROVIDE BEST IN CLASS BLOOD PRODUCTS AND CLINICAL SERVICES TO MEET THE NEEDS OF THE HEALTHCARE COMMUNITY, PATIENTS & OUR DONORS THROUGH ADVANCED TRANSFUSION MEDICINE PRACTICES. X 42 35 1009 126 0 109651 241686 323468 107719965 208305714 1254107 4132446 210714 1051085 109426472 213812713 428244 1152792 0 0 33391579 64621528 0 0 0 76796325 147555484 110616148 213329804 -1189676 482909 203527918 201784319 24824676 18434266 178703242 183350053 X ITXM'S MISSION IS TO PROVIDE BEST IN CLASS BLOOD PRODUCTS AND CLINICAL SERVICES TO MEET THE NEEDS OF THE HEALTHCARE COMMUNITY, PATIENTS AND OUR DONORS THROUGH ADVANCED TRANSFUSION MEDICINE PRACTICES. ITXM'S VISION IS TO BE THE PREMIER PROVIDER OF BLOOD TRANSFUSION PRACTICES BY DELIVERING INNOVATIVE INDUSTRY LEADING SOLUTIONS THAT ENSURE THE HIGHEST QUALITY PRODUCTS AND SERVICES, OPERATING EFFICIENCIES, DONOR SATISFACTION AND IMPROVED PATIENT CARE RESULTING IN THE ACHIEVEMENT OF OUR MISSION. ITXM'S MISSION AND VISION ARE SUPPORTED BY OUR VALUES OF STEWARDSHIP, INTEGRITY, ACCOUNTABILITY, RESPECT, EXCELLENCE AND INNOVATION. false true 112323048 0 104075156 THE PRIMARY PURPOSE OF CENTRAL BLOOD BANK, LIFESOURCE AND VIRGINIA BLOOD SERVICES IS TO PROMOTE PUBLIC PARTICIPATION IN A COMMUNITY-BASED BLOOD PROGRAM. A SUCCESSFUL BLOOD PROGRAM HELPS TO ASSURE AN ADEQUATE AND SAFE BLOOD SUPPLY TO THOSE MEMBERS OF THE COMMUNITY IN NEED. IN ADDITION TO HUMAN BLOOD COLLECTIONS, THE BLOOD BANKS ARE ACTIVELY INVOLVED WITH BONE MARROW AND APHERESIS TISSUE COLLECTIONS. DONOR COUNSELING IS ALSO AN IMPORTANT SERVICE PROVIDED TO THE DONATING PUBLIC. AS OF OCTOBER 2018, VIRGINIA BLOOD SERVICES NO LONGER ACTS AS A BLOOD BANK DUE TO ENTERING INTO AN ASSET PURCHASE AGREEMENT WITH AMERICAN NATIONAL RED CROSS. 34248438 0 44112106 CLINICAL SERVICES PROVIDES BLOOD AND BLOOD-RELATED DIAGNOSTIC TESTS AND PROCEDURES TO ENSURE THAT THE UNITS OF DONATED BLOOD ARE COMPATIBLE WITH SPECIFIC PATIENTS. CLINICAL SERVICES ALSO OPERATES THE ONLY PUBLIC CORD BLOOD BANK IN THE CHICAGO AREA. ITXM DIAGNOSTICS PROVIDES TESTING SERVICES AND UNDERTAKES RESEARCH AND EDUCATIONAL ACTIVITIES WITH RESPECT TO BLEEDING AND CLOTTING DISORDERS AND PROVIDES THERAPEUTIC APHERESIS SERVICES. 52140891 1152792 61127138 THE HEMOPHILIA CENTER OF WESTERN PENNSYLVANIA PROVIDES MEDICAL SERVICES TO PERSONS WITH CONGENITAL BLEEDING AND CLOTTING DISORDERS AND WORKS TO DEVELOP AND SUPPORT EDUCATIONAL, RESEARCH AND THERAPEUTIC SERVICES. THEY OPERATE A 340B DRUG DISTRIBUTION PROGRAM WHICH PROVIDES FUNDS TO SUPPORT PERSONNEL, PERFORM OUTREACH CLINICS, ENHANCE COMMUNICATION VIA WEB SITE AND BROCHURES, IMPROVE BUSINESS OPERATIONS AND CLINICAL CARE THROUGH THE IMPLEMENTAION OF ELECTRONIC MEDICAL RECORDS, SUPPORT OTHER 501(C)(3) ORGANIZATIONS THAT PROVIDE EDUCATION AND CAMP OPPORTUNITIES FOR PATIENTS. 198712377 true true false true false false false false false false true true false false true true false true false false true false false false false false false true false true false false false false false false false false true false false true false true true true false false true X 0 0 1009 true true true false false false false false false false false false false false X 42 35 false false false false true true true true true false false true true true true true true true true false IL PA VA X CHARLES LACLAIR 4122097385 5 PARKWAY CENTER 875 GREENTREE ROAD PITTSBURGH PA 15220 X PATRICIA ABREGO-SANTUCCI VICE CHAIR 1.0 1.0 X X 0 23000 0 SUNNY P CHICO DIRECTOR 1.0 1.0 X 0 23000 0 ROBERT S COLE CHAIR 1.0 1.0 X X 0 33875 0 DAVID GREEN DIRECTOR 1.0 39.0 X 0 690754 55265 MICHAEL H JONES DIRECTOR (THRU 11/18) 1.0 1.0 X 0 20500 0 JOHN S LEWIS DIRECTOR 1.0 1.0 X 0 37000 0 RICHARD D MCHUGH MD DIRECTOR 1.0 1.0 X 0 0 0 JAMES SCHRAITH DIRECTOR 1.0 1.0 X 0 40125 0 PAUL E STANDER MD SECY/TREAS 1.0 1.0 X X 0 23500 0 TANYA PERRY CFO/VBS BOARD 1.0 39.0 X X 0 347293 42361 BHAVI SHAH GEN COUNSL/ASST SECY/VBS BOARD 1.0 39.0 X X 0 367776 36748 EDWARD CHU MD HCWP CHAIR 1.0 0.0 X X 0 0 0 MARK GLADWIN MD HCWP DIRECTOR 1.0 0.0 X 0 0 0 MARGARET V RAGNI MD HCWP MEDICAL DIRECTOR 40.0 0.0 X 0 0 0 A KIM RICHEY MD HCWP DIRECTOR 1.0 0.0 X 0 0 0 DARRELL TRIULZI MD HCWP DIRECTOR 1.0 5.0 X 0 0 0 RALPH VASSALLO MD HCWP DIRECTOR 1.0 39.0 X 0 421919 44855 JENNIFER BOU HCWP DIR/ASST SECY (EFF 4/18) 1.0 39.0 X X 0 177132 30737 MARK J GIAQUINTO HCWP DIR/SECY (THRU 04/18) 1.0 0.0 X X 0 283259 48580 LINDA HAHN VP CLINICAL SVCS (THRU 7/18) 40.0 0.0 X X 130169 0 -473705 ROBERT VAN TUYLE VBS CHAIR (EFF 11/18) 1.0 39.0 X X 0 418714 58254 CHARLES WILCOX III DIVISION PRESIDENT 35.0 5.0 X 0 349623 26534 ANDREA CORTESE HASSETT PHD VP CLINICAL SERVICES 39.0 1.0 X 143776 53795 19210 TODD CAHILL REGIONAL EXECUTIVE DIRECTOR 40.0 0.0 X 167207 0 26669 JASON CRANE LS ASSOCIATE MEDICAL DIRECTOR 40.0 0.0 X 132166 48711 31298 MONA PAPARI LIFESOURCE MEDICAL DIRECTOR 40.0 0.0 X 188716 70747 12891 CHELSEA SHEPPARD VIRGINIA BLOOD SVCS MED DIR 40.0 0.0 X 194980 5123 7957 MICHELE TYSARCZYK SR. DIRECTOR, MANUFACTURING 40.0 0.0 X 48125 127047 10072 DIANE MERKT FORMER VICE PRESIDENT 0.0 0.0 X 0 196216 0 1005139 3759109 -22274 15 true true false CREATIVE TESTING SOLUTIONS 2424 W ERIE DRIVE TEMPE AZ 85282 BLOOD TESTING SVCS 12202201 1 1694 228282 93492 56975 323468 BLOOD PRODUCTS & COMPONENTS 900099 102510949 102510949 FACTOR PROGRAM REVENUE 621400 60994335 60994335 BLOOD & BLOOD RELATED TESTING 900099 44800430 44800430 208305714 934800 934800 0 0 60569 18170 42399 0 42399 42399 16900901 13703255 3197646 3197646 3197646 0 0 0 0 0 0 0 0 0 REVENUE FROM AFFILIATED ORGANIZATIONS 900099 939718 939718 REVENUE FROM RESEARCH 900099 52363 52363 OTHER 900099 16605 16605 1008686 213812713 209314400 4174845 1152792 1152792 0 0 0 273945 0 273945 0 0 50289822 50289822 0 1292525 1292525 7838604 7838604 4926632 4926632 0 142332 142332 8542 8542 3000 3000 0 126095 126095 4041278 4041278 1438837 1438837 7889625 7889625 1304993 1304993 0 6873923 6873923 2228472 2228472 0 25063 25063 0 0 5115349 5115349 266607 266607 FACTOR PROGRAM EXPENSES 48158646 48158646 BLOOD PRODUCTS & COMPONENTS 22946384 22946384 TESTING & LABORATORY SUPPLIES 15516630 15516630 TESTING & LABORATORY SERVICES 14945854 14945854 16523854 2306467 14217387 213329804 198712377 14617427 0 376122 743117 0 0 72681 24975 16900613 14483298 0 0 0 0 0 0 13824233 7302338 549115 407188 48665220 7790842 58081943 40874378 0 0 109347671 128805649 0 0 0 0 4375540 9143376 203527918 201784319 9155644 3878500 530234 591655 334735 0 0 0 0 0 0 0 0 0 0 0 14804063 13964111 24824676 18434266 X 56244971 48852731 122458271 134497322 0 0 178703242 183350053 203527918 201784319 X 482909 2560889 1603013 X false true X true true true X 448649 584869 543260 241686 95096 1913560 194701254 191016919 204815206 107719965 147215634 845468978 0 0 0 0 0 0 0 0 0 0 0 0 0 195149903 191601788 205358466 107961651 147310730 847382538 0 0 0 0 0 0 106983323 104964575 84996384 44499015 87244224 428687521 106983323 104964575 84996384 44499015 87244224 428687521 418695017 1935564 6496025 1672150 1076323 60568 11240630 0 1935564 6496025 1672150 1076323 60568 11240630 0 1074384 1013614 750102 189103 971628 3998831 198159851 199111427 207780718 109227077 148342926 862621999 0.48538 0.50319 0.01303 0.01515 X false false false false false 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 SCHEDULE A, PART III THE IRS EO BUSINESS MASTER FILE ERRONEOUSLY LISTS EACH OF THE ORGANIZATIONS INCLUDED IN THIS RETURN AS A SECTION 509(A)(3) SUPPORTING ORGANIZATION. HOWEVER, ALL ORGANIZATIONS INCLUDED IN THE RETURN ARE EITHER SECTION 509(A)(1) OR 509(A)(2) ORGANIZATIONS. APPROPRIATELY, SCHEDULE A, PART III HAS BEEN COMPLETED FOR THE SECTION 509(A)(2) ORGANIZATIONS, AND SCHEDULE A, PART IV HAS NOT BEEN COMPLETED. BASED ON THE INFORMATION ABOVE, THE REVENUE FOR THE HEMOPHILIA CENTER OF WESTERN PENNSYLVANIA, A SECTION 509(A)(2) ORGANIZATION, HAS BEEN REMOVED FROM THE 2018 DATA. SCHEDULE A, PART III, LINE 12 THE AMOUNT ON LINE 12 DOES NOT INCLUDE CAPITAL GAINS IN THE AMOUNT OF: 2014 $(592) 2015 $23,178 2016 $11,407 2017 $201,927 2018 $3,197,646 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false false false false false false true 3000 false false 3000 false SCHEDULE C, PART II-B, LINE 1G A CONSULTANT IS COMPENSATED TO ACT AS THE EXECUTIVE DIRECTOR AND LEGISLATIVE COORDINATOR FOR THE ILLINOIS COALITION OF COMMUNITY BLOOD CENTERS. THE CONSULTANT RESEARCHES DONOR TRENDS AND WAYS TO IMPROVE BLOOD DONATIONS AND ACTS AS AN ADVOCATE FOR THE SUCCESSFUL PASSAGE OF LEGISLATION THAT WILL HELP INCREASE BLOOD DONATIONS. 704950 4922304 5627254 1086431 32466580 3207855 30345156 802697 621655 181042 5972102 2649519 3322583 2710156 1311813 1398343 40874378 SHORT-TERM INVESTMENTS 115499869 F ALTERNATIVE INVESTMENTS 13305780 F 128805649 0 PAYABLE TO VITALANT 1315017 PAYABLE TO ITXM 10361005 PAYABLE TO BIOCARE 2288089 13964111 X SCHEDULE D PART X, LINE 2 THE SUBSIDIARIES OF THE INSTITUTE FOR TRANSFUSION MEDICINE WERE INCLUDED IN THE CONSOLIDATED AUDITED FINANCIAL STATEMENTS OF VITALANT. AT DECEMBER 31, 2018 THE COMPANY EVALUATED WHETHER IT HAD UNCERTAIN TAX POSITIONS THAT SHOULD BE RECOGNIZED OR DERECOGNIZED BASED ON A 'MORE LIKELY THAN NOT' THRESHOLD FOR TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING THOSE TAX POSITIONS THAT WOULD NOT BE SUSTAINED UPON EXAMINATION IN ACCORDANCE WITH GUIDANCE RELATED TO ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. THE TAX YEARS FOR THE COMPANY THAT ARE SUBJECT TO AUDIT BY THE IRS AND STATE DEPARTMENTS OF REVENUE ARE GENERALLY THE TAX YEARS ENDED DECEMBER 31, 2015, THROUGH THE CURRENT TAX YEAR EXCEPT IN CERTAIN STATES WHERE THE OPEN TAX YEARS GENERALLY BEGIN WITH THE TAX YEAR ENDED DECEMBER 31, 2014. AS OF DECEMBER 31, 2018, THE COMPANY HAS NOT IDENTIFIED ANY UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE THE RECORDING OF A TAX LIABILITY. THE COMPANY DOES NOT ANTICIPATE A CHANGE IN UNCERTAIN TAX POSITIONS FOR THE 12 MONTHS FOLLOWING THE YEAR ENDED DECEMBER 31, 2018. Central America and the Caribbean 0 0 Investments 9104926 Europe (Including Iceland and Greenland) 0 0 Investments 4200854 0 0 0 0 13305780 13305780 false false false false true false true UNIVERSITY OF PITTSBURGH-DEPT OF MEDICINE 1218 SCAIFE HALL PITTSBURGH PA 15261 250965591 501(C)(3) 889792 ESTABLISH A HEMOSTASIS AND VASCULAR BIOLOGY INSTITUTE TO FURTHER BASIC AND CLINIC RESEARCH AND EDUCATION REGARDING BLOOD DISEASES WESTERN PA CHAPTER OF THE HEMOPHILIA FDN 20411 RT 19 UNIT 14 CRANBERRY PA 16066 251359331 501(C)(3) 125000 TO IMPROVE THE LIVES OF THE MEMBERS OF THE BLEEDING DISORDERS COMMUNITY THROUGH EDUCATIONAL PROGRAMS, GUIDANCE AND SUPPORT. PATIENT SERVICES INC PO BOX 1602 MIDLOTHIAN VA 22113 541596178 501(C)(3) 28000 PATIENT ASSISTANCE FOR INSURANCE PREMIUMS TO PATIENTS WITH CHRONIC DISEASES FDN FOR WOMEN & GIRLS WITH BLEEDING DISORDERS 11 CLOVERHILL PLACE MONTCLAIR NJ 04042 272456813 501(C)(3) 100000 ENSURE WOMEN AND ADOLESCENT GIRLS WITH BLOOD DISORDERS ARE CORRECTLY DIAGNOSED AND OPTIMALLY TREATED AND MANAGED AT EVERY LIFE STAGE. CHILDREN'S HOSPITAL OF PHILADELPHIA 3501 CIVIC CENTER BLVD PHILA PA 19104 231352166 501(C)(3) 10000 SUPPORT THE ANNUAL EDUCATIONAL MEETING FOR FEDERALLY FUNDED HEMOPHILIA TREATMENT CENTERS. 5 0 PART I LINE 2 - HEMOPHILIA CENTER OF WESTERN PENNSYLVANIA AS PART OF ITS ANNUAL BUDGET PROCESS, THE HEMOPHILIA CENTER DETERMINES APPROPRIATE LEVELS OF COMMUNITY SUPPORT BASED ON REQUESTS RECEIVED BY 501(C)(3) ORGANIZATIONS WHO SHARE SIMILAR MISSIONS IN SERVICING THE NEEDS OF THE BLEEDING DISORDERS COMMUNITY. THE CENTER REVIEWS ALL REQUESTS ALONG WITH PRIOR FUNDING REPORTS FROM THE ORGANIZATIONS WHICH ARE PRESENTED TO THE CENTER PRESIDENT/MEDICAL DIRECTOR AND EXECUTIVE DIRECTOR AND THEN SUBSEQUENTLY VOTED ON BY THE BOARD DURING THE ADOPTION OF THE ANNUAL BUDGET. EACH FUNDING REQUEST REQUIRES THE RECIPIENT ORGANIZATION TO SIGN A FINANCIAL ASSISTANCE AGREEMENT WHICH STIPULATES THE DURATION OF THE FUNDING, THE AMOUNT OF THE FUNDING, THE INTENDED USE OF THE FUNDS, AND REQUIRES AN ACCOUNTING OF THE UTILIZED FUNDS. ALL RESEARCH GRANT FUNDING PROVIDED BY THE HEMOPHILIA CENTER MUST BE APPROVED BY THE HEALTH RESOURCES AND SERVICES ADMINISTRATION (HRSA). true true false false false false false false false DAVID GREEN DIRECTOR 0 610854 0 68200 0 11700 0 29500 0 25765 0 746019 0 0 TANYA PERRY CFO/VBS BOARD 0 330543 0 7150 0 9600 0 27122 0 15239 0 389654 0 0 BHAVI SHAH GEN COUNSL/ASST SECY/VBS BOARD 0 342776 0 14300 0 10700 0 11000 0 25748 0 404524 0 0 CHARLES WILCOX III DIVISION PRESIDENT 0 321527 0 11462 0 16634 0 11000 0 15534 0 376157 0 7034 RALPH VASSALLO MD HCWP DIRECTOR 0 394161 0 17058 0 10700 0 29500 0 15355 0 466774 0 0 JENNIFER BOU HCWP DIR/ASST SECY (EFF 4/18) 0 174549 0 2348 0 235 0 7275 0 23462 0 207869 0 0 MARK J GIAQUINTO HCWP DIR/SECY (THRU 04/18) 0 282913 0 0 0 346 0 26132 0 22448 0 331839 0 0 DIANE MERKT FORMER VICE PRESIDENT 0 0 0 0 0 196216 0 0 0 0 0 196216 0 0 ANDREA CORTESE HASSETT PHD VP CLINICAL SERVICES 143776 53464 0 0 0 331 -5375 2199 18461 3925 156862 59919 0 0 TODD CAHILL REGIONAL EXECUTIVE DIRECTOR 149580 0 0 0 17627 0 7094 0 19575 0 193876 0 0 0 JASON CRANE LS ASSOCIATE MEDICAL DIRECTOR 132166 48711 0 0 0 0 6404 2104 18872 3918 157442 54733 0 0 MONA PAPARI LIFESOURCE MEDICAL DIRECTOR 188716 70588 0 0 0 159 8522 2839 974 556 198212 74142 0 0 CHELSEA SHEPPARD VIRGINIA BLOOD SVCS MED DIR 179443 5123 0 0 15537 0 7783 42 132 0 202895 5165 0 0 ROBERT VAN TUYLE VBS CHAIR (EFF 11/18) 0 391074 0 16940 0 10700 0 29500 0 28754 0 476968 0 0 MICHELE TYSARCZYK SR. DIRECTOR, MANUFACTURING 48125 112116 0 1000 0 13931 1142 -13400 7765 14565 57032 128212 0 0 PART I PART I, LINE 3 EFFECTIVE MARCH 1, 2017, THE INSTITUTE FOR TRANSFUSION MEDICINE, AMENDED ITS ARTICLES OF INCORPORATION AND BYLAWS SUCH THAT VITALANT, FORMERLY BLOOD SYSTEMS INC, BECAME ITXM'S SOLE CORPORATE MEMBER. THE COMPENSATION OF VITALANT'S CEO IS ESTABLISHED THROUGH THE FOLLOWING METHODS: COMPENSATION COMMITTEE, INDEPENDENT COMPENSATION CONSULTANT, COMPENSATION SURVEY OR STUDY AND APPROVAL BY THE COMPENSATION COMMITTEE. PART I, LINE 4A A SEVERANCE PAYMENT WAS MADE TO: DIANE MERKT-TERMINATED 04/17 $196,216 PART I, LINE 4B LINDA HAHN $432,655 (CASH BALANCE ACCOUNT PAYOUT) CHARLES WILCOX, III $7,034 (SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN DISTRIBUTION) PART II PART I, LINE 7 VITALANT HAS AN INCENTIVE BONUS PLAN FOR MANAGEMENT AND EXECUTIVES. AWARDS UNDER THE PROGRAM ARE AT THE DISCRETION OF THE BOARD OF TRUSTEES. THE PLAN MEASURES PERFORMANCE AGAINST MULTIPLE METRICS WHICH CARRY VARIOUS WEIGHTINGS, THE MOST HEAVILY WEIGHTED BEING QUALITY, SAFETY AND CUSTOMER SERVICE. TO ASSURE FINANCIAL STABILITY OF THE COMPANY, ONE OF THE METRICS IS ALSO A MEASUREMENT OF NET MARGIN FINANCIAL PERFORMANCE AS A PERCENT OF REVENUES. X GIFT CARDS/CERTIFICATES 46 7270 FMV X BREAKFAST/LUNCH/REFRESHMENTS 14 6676 FMV X OTHER 9 43029 FMV false true false FIXED ASSETS 2018-10-31 13468752 BOOK VALUE 530196605 AMERICAN NATIONAL RED CROSS 430 17TH ST NW WASHINGTON DC 20006 501(C)(3) CLOSING COSTS 2018-10-31 28965 FIXED FEE 530196605 AMERICAN NATIONAL RED CROSS 430 17TH ST NW WASHINGTON DC 20006 501(C)(3) false false false false PART II ON OCTOBER 31, 2018, VIRGINIA BLOOD SERVICES ENTERED INTO AN ASSET PURCHASE AGREEMENT WITH AMERICAN NATIONAL RED CROSS, WHEREBY AMERICAN NATIONAL RED CROSS PURCHASED AND ASSUMED SUBSTANTIALLY ALL THE ASSETS AND CERTAIN SPECIFIED LIABILITIES OF VIRGINIA BLOOD SERVICES. AS A RESULT OF THE TRANSACTION, THE COMPANY RECORDED A GAIN ON THE SALE OF THE ASSETS OF APPROXIMATLEY $3.3 MILLION. ON MARCH 29, 2019, VITALANT, THE SOLE CORPORATE MEMBER OF THE INSTITUTE FOR TRANSFUSION MEDICINE, BECAME THE SOLE MEMBER OF VIRGINIA BLOOD SERVICES. VITALANT ANTICIPATES DISSOLVING VIRGINIA BLOOD SERVICES IN THE NEXT SIX MONTHS. PART III, LINE 3 ON OCTOBER 31, 2018, VIRGINIA BLOOD SERVICES (VBS) ENTERED INTO AN ASSET PURCHASE AGREEMENT WITH AMERICAN NATIONAL RED CROSS (ARC), WHEREBY, ARC PURCHASED AND ASSUMED SUBSTAINTILLY ALL THE ASSETS AND CERTAIN SPECIFIED LIABILITIES OF VBS. AT THE TIME OF THE PURCHASE, VBS CEASED OPERATIONS. PART V, SECTION A, LINE 1 IN 2018, VENDOR PAYMENTS WERE MADE BY VITALANT. PART VI, SECTION A, LINE 6 THE INSTITUTE FOR TRANSFUSION MEDICINE IS THE SOLE CORPORATE MEMBER OF EACH ORGANIZATION THAT IS INCLUDED IN THIS FORM 990. PART VI, SECTION A, LINES 7A & 7B THE INSTITUTE FOR TRANSFUSION MEDICINE, AS THE SOLE CORPORATE MEMBER OF EACH ORGANIZATION INCLUDED IN THE GROUP RETURN, HAS THE POWER TO CARRY OUT THE LISTED FUNCTIONS WITH RESPECT TO EACH ORGANIZATION INCLUDED IN THE GROUP RETURN: (A) OVERSEE AND MONITOR THE CONDUCT OF THE BUSINESS AND ACTIVITIES TO DETERMINE WHETHER THEY ARE PROPERLY MANAGED IN RELATION TO THE CHARITABLE, COMMUNITY SERVICE AND STRATEGIC MISSION AND GOALS OF THE CORPORATION AND IN COMPLIANCE WITH APPLICABLE LAWS, REGULATIONS AND BOARD-MANDATED POLICIES; (B) EXERT FINAL DECISION-MAKING AUTHORITY OVER CHOICES RELATING TO ORGANIZATIONAL STRUCTURE, STRATEGIC GOALS AND ECONOMIC OBJECTIVES, MAJOR OPERATING POLICIES AND SIGNIFICANT FINANCIAL ACCOUNTING PRINCIPLES AND PRACTICES; (C) SELECT, REGULARLY EVALUATE, FIX THE COMPENSATION OF AND (WHEN APPROPRIATE) REPLACE THE SENIOR EXECUTIVE OFFICERS AND THE MEMBERS OF THE BOARD; (D) SELECT EXTERNAL CERTIFIED PUBLIC ACCOUNTANTS TO CONDUCT AN ANNUAL EXAMINATION AND AUDIT OF THE CORPORATION'S FINANCIAL STATEMENTS; (E) SELECT CORPORATE LEGAL COUNSEL TO ADVISE THE BOARD IN PERFORMING ITS FUNCTIONS AND THE MEMBERS OF THE BOARD IN PERFORMING THEIR FIDUCIARY DUTIES; (F) REVIEW AND APPROVE MAJOR PLANS, COMMITMENTS AND INITIATIVES, INCLUDING ACQUISITIONS, DIVESTITURES AND CAPITAL EXPENDITURE PROGRAMS AND PROJECTS, PROPOSED BY THE SENIOR EXECUTIVE OFFICERS, ALL WITH DUE REGARD FOR POTENTIAL BENEFITS AND RISKS RELATIVE TO THE CORPORATION'S CHARITABLE, COMMUNITY SERVICE AND STRATEGIC MISSION AND GOALS; (G) PROVIDE ADVICE AND GUIDANCE TO THE SENIOR EXECUTIVE OFFICERS IN CONNECTION WITH THE BUSINESS AND ACTIVITIES AND ASSIST IN GAINING ACCESS TO KEY EXTERNAL RESOURCES FOR ADVANCEMENT OF THE CHARITABLE AND COMMUNITY SERVICE MISSION; AND (H) EXERCISE SUCH OTHER POWERS AS HAVE BEEN DELEGATED AND PERFORM SUCH OTHER FUNCTIONS AS ARE PRESCRIBED BY APPLICABLE LAWS AND REGULATIONS. PART VI, SECTION B, LINE 11 THE 990 IS COMPLETED BY MANAGEMENT AND IS REVIEWED BY AN EXTERNAL, INDEPENDENT ACCOUNTING FIRM. THE 990 HAS BEEN REVIEWED BY THE PARENT'S EXECUTIVE LEADERSHIP AND A COPY HAS BEEN SENT TO THE BOARD GOVERNING THE SUBSIDIARIES FOR THEIR REVIEW PRIOR TO FILING. PART VI, SECTION B, LINE 12C EACH YEAR, THE BOARD OF DIRECTORS AND SENIOR MANAGEMENT ARE REQUIRED TO SIGN AND RETURN A CONFLICT OF INTEREST FORM TO COMPANY COUNSEL. ANY CONFLICTS DISCLOSED ARE DISCUSSED IN EXECUTIVE SESSION WITH THE BOARD AND RESOLVED. IN ADDITION, IN PREPARATION FOR THE FORM 990 FILING, THE DIRECTORS, OFFICERS AND KEY EMPLOYEES IDENTIFIED ARE REQUIRED TO RESPOND TO A COMPREHENSIVE CONFLICT OF INTEREST AND FAMILY RELATIONSHIP QUESTIONNAIRE. ANY CONFLICTS ARE DISCUSSED WITH THE BOARD AND DISCLOSED APPROPRIATELY ON THE FORM 990. PART VI, SECTION B, LINE 15 THE BOARD OF TRUSTEES OF VITALANT HAS A COMPENSATION AND HUMAN RESOURCES COMMITTEE WHOSE PURPOSE, AMONG OTHER THINGS, IS TO HIRE AN INDEPENDENT CONSULTING FIRM ONCE EVERY 2-3 YEARS TO PROVIDE DATA ON COMPETITIVENESS OF SALARIES AND BENEFITS FOR THE CEO AND OTHER OFFICERS OF THE CORPORATION. THE MEMBERS OF THE HUMAN RESOURCES AND COMPENSATION COMMITTEE OF THE BOARD ARE ALL INDEPENDENT TRUSTEES AND INCLUDE NO MEMBERS OF MANAGEMENT. THE RECOMMENDATIONS OF THE COMMITTEE ARE REVIEWED BY THE ENTIRE BOARD PRIOR TO APPROVAL. COMPENSATION FOR THESE INDIVIDUALS IS SET AND APPROVED BY THE BOARD EACH YEAR. THE RESULTS OF THESE DISCUSSIONS, REVIEWS AND APPROVALS ARE DOCUMENTED IN THE EXECUTIVE SESSION MINUTES OF THE BOARD MEETINGS. THIS PROCESS WAS LAST COMPLETED IN 2017. PART VI, SECTION C LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. PART VII, SECTION A EFFECTIVE WITH THE VITALANT MERGER, THE BOARD OF DIRECTORS FOR CENTRAL BLOOD BANK, LIFESOURCE BLOOD SERVICES, VIRGINIA BLOOD SERVICES, ITXM CLINICAL SERVICES AND ITXM DIAGNOSTICS MIRROR THAT OF ITXM. AS SUCH, THE FOLLOWING ITXM BOARD MEMBERS AND OFFICERS ALSO SERVE AS BOARD MEMBERS AND OFFICERS FOR THESE ENTITIES: PATRICIA ABREGO-SANTUCCI SUNNY CHICO ROBERT COLE DAVID GREEN MICHAEL JONES (THRU 11/18) JOHN LEWIS RICHARD MCHUGH, MD JAMES SCHRAITH PAUL STANDER, MD TANYA PERRY BHAVI SHAH CHARLES WILCOX AS OF DECEMBER 31, 2018, ALL INDIVIDUALS THAT HAD PREVIOUSLY BEEN EMPLOYED BY THE FILING ORGANIZATIONS WERE ON-BOARDED AS EMPLOYEES OF VITALANT, THE PARENT ORGANIZATION OF ITXM AND ITS SUBSIDIARIES. AS THE DIRECTION AND CONTROL OF ALL EMPLOYEES NOW LIES WITH VITALANT, ITXM AND ITS SUBSIDIARIES WILL NOT REPORT CURRENT EMPLOYEES ON FUTURE FORMS 990. PART XI, LINE 9 NET ASSET FMV ADJUSTMENT $1,603,013 BLOOD SCIENCE FOUNDATION 875 GREENTREE ROAD PARKWAY CENTER PITTSBURGH PA 15220 251562715 FUNDRAISING PA 501(c)(3) 12D NA false VITALANT 6210 E OAK ST SCOTTSDALE AZ 85257 860098929 BLOOD BANK AZ 501(C)(3) 10 NA false BLOOD BANK SAN BERNARDINORIVERSIDE FDN POBOX 1429 SAN BERNARDINO CA 92402 208911074 FUNDRAISING CA 501(C)(3) 12-TYPE I BBSBRC true GEISINGER BLOOD CTR PC5 875GRNTRE RD PGH PA 15220 364718005 BLOOD BANK PA NA N/A CANYON STATE INSURANCE COMPANY PO BOX 1085 113 S CHURCH ST GRAND CAYMAN CJ KY1-1102 941084327 CAPTIVE INS. CJ NA FOREIGN BIOCARE INC 6210 E OAK ST SCOTTSDALE AZ 85257 813906720 PHARMA AZ N/A C CORP TRANSFUSION TECHNOLOGY INC 102 CHESTNUT RIDGE ROAD MONTVALE NJ 07645 223494865 INACTIVE NJ N/A C CORP false false false false false false false false false false false true true false false true true false true INSTITUTE FOR TRANSFUSION MEDICINE P 16000000 FMV BLOOD BANK OF SAN BERNARDINO & RIVERSIDE P 597848 FMV BERGEN COMMUNITY REGIONAL BLOOD CENTER INC P 298844 FMV BERGEN COMMUNITY REGIONAL BLOOD CENTER INC Q 405354 FMV BIOCARE INC P 16777729 FMV BIOCARE INC M 1995676 FMV BIOCARE INC L 66767 FMV VITALANT M 16080891 FMV VITALANT P 88374154 FMV VITALANT Q 561768 FMV VITALANT S 16810472 FMV CENTRAL BLOOD BANK 5 PARKWAY CENTER 875 GREENTREE RD PITTSBURGH PA 15220 251055312 INST LIFESOURCE 5 PARKWAY CENTER 875 GREENTREE RD pittsburgh PA 15220 363492969 INST ITXM CLINICAL SERVICES 5 PARKWAY CENTER 875 GREENTREE RD PITTSBURGH PA 15220 251839168 INST HEMOPHILIA CENTER OF WESTERN PA 5 PARKWAY CENTER 875 GREENTREE RD PITTSBURGH PA 15220 251562716 INST itxm diagnostics inc 5 PARKWAY CENTER 875 GREENTREE RD pittsburgh PA 15220 030497690 INST VIRGINIA BLOOD SERVICES 5 PARKWAY CENTER 875 GREENTREE RD PITTSBURGH PA 15220 540959121 INST